Cargando…
Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways
Introduction: Recent studies in our laboratory have shown that some bile acids, such as chenodeoxycholic acid (CDCA), can exert cellular protective effects when encapsulated with viable β-cells via anti-inflammatory and anti-oxidative stress mechanisms. However, to explore their full potential, form...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398365/ https://www.ncbi.nlm.nih.gov/pubmed/34452145 http://dx.doi.org/10.3390/pharmaceutics13081184 |
_version_ | 1783744822133129216 |
---|---|
author | Mooranian, Armin Foster, Thomas Ionescu, Corina M. Walker, Daniel Jones, Melissa Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Johnston, Edan Wong, Elaine Atlas, Marcus D. Mikov, Momir Al-Salami, Hani |
author_facet | Mooranian, Armin Foster, Thomas Ionescu, Corina M. Walker, Daniel Jones, Melissa Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Johnston, Edan Wong, Elaine Atlas, Marcus D. Mikov, Momir Al-Salami, Hani |
author_sort | Mooranian, Armin |
collection | PubMed |
description | Introduction: Recent studies in our laboratory have shown that some bile acids, such as chenodeoxycholic acid (CDCA), can exert cellular protective effects when encapsulated with viable β-cells via anti-inflammatory and anti-oxidative stress mechanisms. However, to explore their full potential, formulating such bile acids (that are intrinsically lipophilic) can be challenging, particularly if larger doses are required for optimal pharmacological effects. One promising approach is the development of nano gels. Accordingly, this study aimed to examine biological effects of various concentrations of CDCA using various solubilising nano gel systems on encapsulated β-cells. Methods: Using our established cellular encapsulation system, the Ionic Gelation Vibrational Jet Flow technology, a wide range of CDCA β-cell capsules were produced and examined for morphological, biological, and inflammatory profiles. Results and Conclusion: Capsules’ morphology and topographic characteristics remained similar, regardless of CDCA or nano gel concentrations. The best pharmacological, anti-inflammatory, and cellular respiration, metabolism, and energy production effects were observed at high CDCA and nano gel concentrations, suggesting dose-dependent cellular protective and positive effects of CDCA when incorporated with high loading nano gel. |
format | Online Article Text |
id | pubmed-8398365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83983652021-08-29 Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways Mooranian, Armin Foster, Thomas Ionescu, Corina M. Walker, Daniel Jones, Melissa Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Johnston, Edan Wong, Elaine Atlas, Marcus D. Mikov, Momir Al-Salami, Hani Pharmaceutics Article Introduction: Recent studies in our laboratory have shown that some bile acids, such as chenodeoxycholic acid (CDCA), can exert cellular protective effects when encapsulated with viable β-cells via anti-inflammatory and anti-oxidative stress mechanisms. However, to explore their full potential, formulating such bile acids (that are intrinsically lipophilic) can be challenging, particularly if larger doses are required for optimal pharmacological effects. One promising approach is the development of nano gels. Accordingly, this study aimed to examine biological effects of various concentrations of CDCA using various solubilising nano gel systems on encapsulated β-cells. Methods: Using our established cellular encapsulation system, the Ionic Gelation Vibrational Jet Flow technology, a wide range of CDCA β-cell capsules were produced and examined for morphological, biological, and inflammatory profiles. Results and Conclusion: Capsules’ morphology and topographic characteristics remained similar, regardless of CDCA or nano gel concentrations. The best pharmacological, anti-inflammatory, and cellular respiration, metabolism, and energy production effects were observed at high CDCA and nano gel concentrations, suggesting dose-dependent cellular protective and positive effects of CDCA when incorporated with high loading nano gel. MDPI 2021-07-31 /pmc/articles/PMC8398365/ /pubmed/34452145 http://dx.doi.org/10.3390/pharmaceutics13081184 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mooranian, Armin Foster, Thomas Ionescu, Corina M. Walker, Daniel Jones, Melissa Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Johnston, Edan Wong, Elaine Atlas, Marcus D. Mikov, Momir Al-Salami, Hani Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways |
title | Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways |
title_full | Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways |
title_fullStr | Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways |
title_full_unstemmed | Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways |
title_short | Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways |
title_sort | enhanced bilosomal properties resulted in optimum pharmacological effects by increased acidification pathways |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398365/ https://www.ncbi.nlm.nih.gov/pubmed/34452145 http://dx.doi.org/10.3390/pharmaceutics13081184 |
work_keys_str_mv | AT mooranianarmin enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT fosterthomas enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT ionescucorinam enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT walkerdaniel enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT jonesmelissa enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT waglesusbinraj enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT kovacevicbozica enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT chesterjacqueline enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT johnstonedan enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT wongelaine enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT atlasmarcusd enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT mikovmomir enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways AT alsalamihani enhancedbilosomalpropertiesresultedinoptimumpharmacologicaleffectsbyincreasedacidificationpathways |